CEACAM5 and non-Hodgkin lymphoma: CD66 is part of the carcinoembryonic antigen (CEA) family of receptors, which are expressed on various myeloid and lymphoid cells, such as granulocytes and B cells, as well as in malignant disease, such as NHL and MM [105–107].